Ro Khanna
Democrat House (CA) Committee Conflict

Ro Khanna × JNJ

Johnson & Johnson (Pharmaceuticals)

88
Disclosed Trades
$950K
Total Buys
9y
Stacking
The Conflict

88 JNJ Disclosures, Tech-Focused Member × Pharma Giant

Ro Khanna represents Silicon Valley and sits on committees focused on cybersecurity, defense technology, and government oversight, not pharmaceutical regulation. However, the sheer volume of disclosed trades in Johnson and Johnson, 88 in total according to public disclosure data, makes this pairing structurally notable regardless of direct jurisdictional overlap. Johnson and Johnson is subject to federal drug pricing legislation, FDA oversight, and healthcare policy debates that regularly pass through the House floor. Khanna's family trust has generated one of the highest trade volumes in Congress, and the frequency and occasional clustering of JNJ transactions across this record invites scrutiny of the broader pattern even absent a direct committee hook.

Johnson and Johnson is a diversified healthcare company generating revenue from pharmaceuticals, medical devices, and consumer health products. Its pricing, patent policy, and product approvals are directly subject to federal legislative and regulatory action, including drug pricing reform and FDA oversight.

House Committee on Armed Services, Subcommittee on Cyber, Information Technologies, and Innovation (Ranking Member)
Oversees defense technology and digital modernization. Johnson and Johnson supplies medical and pharmaceutical products to military health systems, creating a secondary procurement angle alongside its broader federal regulatory exposure.
House Committee on Oversight and Government Reform, Subcommittee on Cybersecurity, Information Technology, and Government Innovation
Oversees federal agency operations and government contracting. Pharmaceutical companies including Johnson and Johnson interact with federal health agencies and government procurement programs that fall within this committee's broad investigative mandate.
Select Committee on Strategic Competition Between the United States and the Chinese Communist Party
Examines supply chain and trade dependencies. Johnson and Johnson, like major pharmaceutical manufacturers, has significant global supply chain exposure relevant to U.S.-China competition policy discussions before this committee.

Trade-by-trade conflict scoring

Showing the 10 most recent of 88 disclosed trades. Each is scored against five rule-based signals.

Trade Date
May 19, 2025
Size
$1K
Conflict Score
0 Low
Committee Overlap
no fire
Pre-Vote Timing
no fire
Late Disclosure
no fire
Unusually Large
no fire
Member Cluster
no fire
Why each signal fired or did not
  • Committee Overlap: Khanna's committees focus on defense technology and oversight; no direct pharmaceutical or FDA jurisdiction applies here.
  • Pre-Vote Timing: Vote calendar data not yet ingested for this dataset.
  • Late Disclosure: Filed 22 days after the trade, within both the 30-day internal flag threshold and the 45-day STOCK Act deadline.
  • Unusually Large: Transaction size of $1,001 equals the median for this politician-ticker pair, showing no size anomaly.
  • Member Cluster: Only 2 members traded JNJ in the surrounding 14-day window, below the 3-member cluster threshold.
Analyst note

This May 2025 sell of $1,001 in Johnson and Johnson is the most recent of 88 disclosed transactions in this stock according to public disclosure data. No signals fired on this individual trade: the disclosure was timely at 22 days, the size matches the typical minimum-bracket transaction, and only two members traded JNJ in the surrounding window. Viewed in isolation, this trade carries low signal density. Its significance lies primarily in context: it is one data point in a high-frequency pattern across a large portfolio managed by Khanna's family trust. Khanna has publicly stated he does not direct the trades and supports a congressional stock trading ban. The committee overlap signal did not fire because Khanna's formal jurisdictions center on defense technology and government oversight rather than pharmaceutical regulation or FDA policy.

Trade Date
May 28, 2025
Size
$1K
Conflict Score
0 Low
Committee Overlap
no fire
Pre-Vote Timing
no fire
Late Disclosure
no fire
Unusually Large
no fire
Member Cluster
no fire
Why each signal fired or did not
  • Committee Overlap: Khanna's committee assignments do not directly cover pharmaceutical regulation or FDA oversight relevant to Johnson and Johnson.
  • Pre-Vote Timing: Vote calendar data not yet ingested for this dataset.
  • Late Disclosure: Disclosed 13 days after the trade, well within both the 30-day internal flag threshold and the 45-day STOCK Act deadline.
  • Unusually Large: At $1,001, this trade sits at the median size and shows no scale anomaly relative to historical norms.
  • Member Cluster: Only 1 member traded JNJ in the 14-day window, far below the 3-member threshold required to flag clustering.
Analyst note

This May 28, 2025 sell of $1,001 in Johnson and Johnson was disclosed promptly in 13 days and draws no flags on any signal. The trade is a minimum-bracket transaction consistent with automated or systematic portfolio activity. No other members traded JNJ in the surrounding two-week window, and the size provides no distinguishing information. As part of the broader 88-trade record in this ticker, this transaction reinforces the pattern of frequent, small-lot activity interspersed with occasional larger trades. Khanna's committees do not sit in the pharmaceutical oversight space, limiting the direct regulatory-exposure argument for this pairing, though Johnson and Johnson's scale means it touches multiple federal policy areas including defense health procurement and drug pricing legislation that periodically reach the House floor.

Trade Date
Jun 20, 2025
Size
$1K
Conflict Score
2 Medium
Committee Overlap
no fire
Pre-Vote Timing
no fire
Late Disclosure
no fire
Unusually Large
no fire
Member Cluster
+2 pts
Why each signal fired or did not
  • Committee Overlap: Khanna's confirmed committees cover defense technology and oversight, not pharmaceutical or FDA policy directly applicable to Johnson and Johnson.
  • Pre-Vote Timing: Vote calendar data not yet ingested for this dataset.
  • Late Disclosure: Filed 19 days after the trade, comfortably within the 30-day internal flag threshold and the 45-day statutory deadline.
  • Unusually Large: Trade size of $1,001 matches the median for this politician-ticker pair; no size anomaly detected.
  • Member Cluster: Four members traded JNJ within the 14-day window, meeting the 3-member cluster threshold and suggesting broader congressional activity.
Analyst note

This June 20, 2025 sell of $1,001 in Johnson and Johnson is individually modest, a minimum-bracket transaction filed within 19 days. However, the member cluster signal fires here: four members of Congress traded JNJ within the surrounding 14-day window, meeting the threshold that suggests the trade may reflect a shared informational environment or a common reaction to public market or policy developments affecting the company. Cluster activity does not confirm coordination, but it raises the question of what observable or non-public factor was drawing multiple members to the same stock at the same time. The sell direction, combined with clustering, is worth tracking against public news and policy developments in the pharmaceutical sector during late June 2025. This trade is one of 88 in the disclosed record for this pairing.

Trade Date
Jun 23, 2025
Size
$15K
Conflict Score
3 Medium
Committee Overlap
no fire
Pre-Vote Timing
no fire
Late Disclosure
no fire
Unusually Large
+1 pts
Member Cluster
+2 pts
Why each signal fired or did not
  • Committee Overlap: Khanna's committees address defense technology and oversight rather than pharmaceutical regulation, limiting direct jurisdictional overlap with Johnson and Johnson.
  • Pre-Vote Timing: Vote calendar data not yet ingested for this dataset.
  • Late Disclosure: Disclosed 16 days after the trade, within both the 30-day internal flag threshold and the 45-day STOCK Act deadline.
  • Unusually Large: At $15,001, this sell is approximately 15 times the median trade size of $1,001 for this politician-ticker pair.
  • Member Cluster: Four members traded JNJ in the surrounding 14-day window, meeting the cluster threshold alongside this elevated-size sell.
Analyst note

This June 23, 2025 sell of $15,001 in Johnson and Johnson is the highest-signal trade in this recent batch. Two signals fire simultaneously: the trade is roughly 15 times the median size for this politician-ticker pair, and four members of Congress were active in JNJ within the same 14-day window. The combination of an outsized sell and congressional clustering makes this the most structurally notable transaction among the 10 most recent. The disclosure was timely at 16 days, so no filing delay concern applies. Viewed alongside the preceding $1,001 sell on June 20 (Trade 5270), which also triggered the cluster signal, a pattern of accelerated selling in the final days of June 2025 emerges. Within the larger 88-trade record, elevated-size transactions like this one stand out as departure points from the otherwise minimum-bracket cadence.

Trade Date
Jul 1, 2025
Size
$1K
Conflict Score
2 Medium
Committee Overlap
no fire
Pre-Vote Timing
no fire
Late Disclosure
+2 pts
Unusually Large
no fire
Member Cluster
no fire
Why each signal fired or did not
  • Committee Overlap: No direct pharmaceutical or FDA jurisdiction established for Khanna's confirmed committee assignments.
  • Pre-Vote Timing: Vote calendar data not yet ingested for this dataset.
  • Late Disclosure: Filed 37 days after the July 1 trade, exceeding the 30-day internal flag threshold, though within the 45-day STOCK Act statutory deadline.
  • Unusually Large: Trade size of $1,001 is at the median for this pair and presents no size anomaly.
  • Member Cluster: Only 2 members traded JNJ in the surrounding 14-day window, below the 3-member cluster threshold.
Analyst note

This July 1, 2025 sell of $1,001 in Johnson and Johnson was not disclosed until August 7, a 37-day delay that exceeds Kapitol.ai's 30-day internal flag threshold. It is worth noting this delay does not breach the STOCK Act's 45-day statutory deadline, so no legal violation is implied. Still, a gap of over five weeks between a transaction and its public filing is longer than the typical turnaround observed in earlier trades in this record, several of which were filed in under two weeks. The trade itself is minimal in size and occurred with no concurrent cluster activity. Within the 88-trade pattern, this is one of several instances where the filing cadence slows, which can reflect administrative lag in trust-managed accounts but is flagged here for transparency.

Trade Date
Jul 25, 2025
Size
$15K
Conflict Score
1 Low
Committee Overlap
no fire
Pre-Vote Timing
no fire
Late Disclosure
no fire
Unusually Large
+1 pts
Member Cluster
no fire
Why each signal fired or did not
  • Committee Overlap: Khanna's confirmed committee roles do not cover pharmaceutical or drug pricing policy directly relevant to Johnson and Johnson.
  • Pre-Vote Timing: Vote calendar data not yet ingested for this dataset.
  • Late Disclosure: Disclosed 13 days after the trade, well within the 30-day internal flag threshold and the 45-day statutory deadline.
  • Unusually Large: At $15,001, this buy is approximately 15 times the $1,001 median size for this politician-ticker pair.
  • Member Cluster: Only 2 members traded JNJ in the surrounding 14-day window, below the 3-member cluster threshold.
Analyst note

This July 25, 2025 buy of $15,001 in Johnson and Johnson is notable for its size relative to the typical trade in this record. At approximately 15 times the median transaction value for this politician-ticker pair, it represents one of the larger disclosed positions in the recent 10-trade window. The disclosure was prompt at 13 days, and no cluster activity surrounded it. Contextually, this elevated buy follows the elevated sell of $15,001 on June 23 (Trade 5159), suggesting the trust may be actively managing position size in JNJ rather than passively holding. The absence of a cluster signal here distinguishes this buy from the earlier sell, indicating fewer members were concurrently active in JNJ around late July. Across 88 disclosed trades, $15,001-bracket transactions appear periodically and represent a meaningfully different allocation decision than the dominant minimum-bracket trades.

Trade Date
Aug 4, 2025
Size
$1K
Conflict Score
2 Medium
Committee Overlap
no fire
Pre-Vote Timing
no fire
Late Disclosure
+2 pts
Unusually Large
no fire
Member Cluster
no fire
Why each signal fired or did not
  • Committee Overlap: No confirmed direct overlap between Khanna's defense and oversight committee roles and Johnson and Johnson's pharmaceutical operations.
  • Pre-Vote Timing: Vote calendar data not yet ingested for this dataset.
  • Late Disclosure: Filed 36 days after the August 4 trade, exceeding Kapitol.ai's 30-day flag threshold but within the 45-day STOCK Act statutory deadline.
  • Unusually Large: Trade size of $1,001 equals the median for this pair, presenting no scale anomaly.
  • Member Cluster: Only 2 members traded JNJ in the surrounding 14-day window, below the 3-member cluster threshold.
Analyst note

This August 4, 2025 buy of $1,001 in Johnson and Johnson carries one flag: its disclosure was filed 36 days after the transaction, exceeding Kapitol.ai's 30-day internal benchmark. As with Trade 4852, this delay does not constitute a STOCK Act violation given the 45-day statutory deadline, but it is the second instance in this 10-trade window where the filing lag crossed the 30-day mark. The trade itself is minimum-bracket and occurred with no concurrent cluster activity from other members. The disclosure pattern across these 10 trades shows a variable filing cadence: some transactions are reported in under a week while others approach the statutory limit. For a trust-managed account with high trading volume, administrative factors may explain this variability, but the pattern is noted across the 88-trade record.

Trade Date
Sep 29, 2025
Size
$1K
Conflict Score
0 Low
Committee Overlap
no fire
Pre-Vote Timing
no fire
Late Disclosure
no fire
Unusually Large
no fire
Member Cluster
no fire
Why each signal fired or did not
  • Committee Overlap: Khanna's committee jurisdictions do not directly encompass pharmaceutical regulation or Johnson and Johnson's core business lines.
  • Pre-Vote Timing: Vote calendar data not yet ingested for this dataset.
  • Late Disclosure: Disclosed just 4 days after the trade, among the fastest filings in this 10-trade window.
  • Unusually Large: At $1,001, the trade is at the median size and shows no scale anomaly for this politician-ticker pair.
  • Member Cluster: Only 1 member traded JNJ in the surrounding 14-day window, well below the 3-member cluster threshold.
Analyst note

This September 29, 2025 buy of $1,001 in Johnson and Johnson is the cleanest trade in the recent 10-transaction window by signal count: no flags fire across any of the five signals. The 4-day disclosure turnaround is the fastest observed in this batch. The trade is minimum-bracket, no other members were concurrently active in JNJ, and no committee overlap is established. It represents a baseline data point in the 88-trade record, illustrating the kind of routine, promptly disclosed transaction that characterizes much of the volume when controlling for outliers. The absence of any flags here is useful for comparison against the trades in this window that did trigger signals, particularly the clustered and oversized sells from June 2025.

Trade Date
Oct 30, 2025
Size
$1K
Conflict Score
2 Medium
Committee Overlap
no fire
Pre-Vote Timing
no fire
Late Disclosure
no fire
Unusually Large
no fire
Member Cluster
+2 pts
Why each signal fired or did not
  • Committee Overlap: Khanna's committees focus on defense technology and government oversight, with no direct pharmaceutical jurisdiction confirmed.
  • Pre-Vote Timing: Vote calendar data not yet ingested for this dataset.
  • Late Disclosure: Filed 7 days after the trade, a prompt disclosure well within both the internal and statutory thresholds.
  • Unusually Large: Trade size of $1,001 is at the median and presents no size anomaly relative to the historical pattern.
  • Member Cluster: Three members traded JNJ in the surrounding 14-day window, exactly meeting the cluster threshold for this signal.
Analyst note

This October 30, 2025 buy of $1,001 in Johnson and Johnson was filed promptly in 7 days and is minimum-bracket in size, but the member cluster signal fires: three members of Congress traded JNJ in the surrounding 14-day window, meeting the threshold exactly. Cluster activity at the minimum threshold is weaker evidence than a higher count, but the pattern still suggests some degree of shared timing among congressional traders. This is the second cluster-flagged buy in the recent 10-trade window (alongside Trade 905 below). The buy direction here, following the mid-year selling activity in June, may reflect a re-entry or position rebuild in JNJ. Across the 88-trade record, the interplay between selling phases and subsequent buying in this stock is one of the more analytically interesting structural features of the portfolio's JNJ exposure.

Trade Date
Nov 7, 2025
Size
$15K
Conflict Score
5 High
Committee Overlap
no fire
Pre-Vote Timing
no fire
Late Disclosure
+2 pts
Unusually Large
+1 pts
Member Cluster
+2 pts
Why each signal fired or did not
  • Committee Overlap: Khanna's confirmed committees address defense technology and oversight, not pharmaceutical or FDA policy directly applicable to Johnson and Johnson.
  • Pre-Vote Timing: Vote calendar data not yet ingested for this dataset.
  • Late Disclosure: Filed 31 days after the November 7 trade, exceeding the 30-day internal flag threshold, though within the 45-day STOCK Act statutory deadline.
  • Unusually Large: At $15,001, this buy is approximately 15 times the $1,001 median size for this politician-ticker pair.
  • Member Cluster: Three members traded JNJ in the surrounding 14-day window, meeting the cluster threshold alongside this elevated-size buy.
Analyst note

This November 7, 2025 buy of $15,001 in Johnson and Johnson is the highest-signal trade in this 10-trade window alongside Trade 5159: three signals fire simultaneously. The transaction is approximately 15 times the median size for this pair, three members traded JNJ in the surrounding 14-day window, and the disclosure arrived 31 days after the trade, exceeding Kapitol.ai's 30-day internal flag threshold. The delay does not breach the STOCK Act's 45-day statutory deadline, so no legal violation is implied. The combination of an elevated buy, concurrent cluster activity, and a slow filing is the most notable signal configuration in this recent batch. This $15,001 buy follows a $15,001 buy on July 25 (Trade 4226) and continues a pattern across the 88-trade record where the larger-bracket transactions occasionally coincide with multi-member activity in the same stock around the same period.

Summary across these 10 trades

Between May 19, 2025 and Nov 7, 2025, Ro Khanna bought $33K and sold $19K of JNJ across 10 disclosed transactions. 30% (3 of 10) were filed past the 30-day STOCK Act window, and 30% (3 of 10) were unusually large relative to Ro Khanna's historical median trade size.

The other 78 trades (not yet individually analysed)

Across the remaining 78 disclosed JNJ trades between Feb 27, 2017 and May 9, 2025, Ro Khanna bought $386K and sold $512K of JNJ. 29% (23 of 78) were filed past the 30-day STOCK Act window, and 45% (35 of 78) sat above twice Ro Khanna's historical median trade size.

Late-filing and unusual-size flags are computed deterministically from the underlying disclosure columns. Per-trade narratives, committee overlap, and member-cluster scoring are restricted to the 10 most recent transactions above.

Scoring methodology

Every trade in the public dataset is scored against five rule-based signals. The score is auditable, not AI-guessed. AI is used only to write the analyst note, never to decide whether a signal fired.

  • Committee Overlap (+3): politician sat on a committee overseeing the company's sector at the time of the trade.
  • Pre-Vote Timing (+3 / +2): politician voted on legislation directly affecting the company within 30 (+3) or 60 (+2) days of the trade.
  • Late Disclosure (+2): filing arrived more than 30 days after the trade (STOCK Act allows 45).
  • Unusually Large (+1): position size sits above the politician's own historical baseline.
  • Member Cluster (+2): three or more members bought the same ticker within a 14-day window.

Score bands: Low (0-1), Medium (2-3), High (4-5), Critical (6+).

Live trades hitting now

You just read about old trades. Hundreds more are disclosed every month.

The same scoring you just saw, applied to every Congress trade as it hits the wire. Members are still trading. You're still not seeing it in time.

30-day money-back guarantee